Main > A1. CORP. INDEX. A-Am No. 1 > Abbott Laboratories Inc./P C2

---

This data is not available for free

Abbott Laboratories Inc./P C2's subsections
2002. 03.16.2002. (Obesity)
2002. 04.01.2002. (Cardiology)
2002. 04.01.2002. (Comments)
2002. 04.29.2002. (Parent of)
2002. 09.23.2002. (BioPharma)
2002. 09.23.2002. (Cardiology)
2002. 09.23.2002. (Onco.)
2002. 09.23.2002. (Urology)
2002. 10.14.2002. (Obesity)
2002. 11.04.2002. (Arthritis)
2002. 11.04.2002. (BioPharma)
2002. 11.11.2002. (Chiral Addition)
2002. 11.11.2002. (Member of)
2002. 12.02.2002. (Contract Mfg.)
2002. 12.02.2002. (Fut Blockbuster)
2002. 12.02.2002. (Onco.)
2002. 12.02.2002. (Pneumology)
2003. 01.20.2003. (Arthritis)
2003. 01.27.2003. (Human Ab Deal)
2003. 02.24.2003. (AIDS)
2003. 03.17.2003. (Arthritis)
2003. 05.05.2003. (Pneumology)
2003. 06.02.2003. (AIDS)
2003. 06.02.2003. (AIDS)
2003. 07.29.2003. (RNAi Deal)
2003. 08.04.2003. (Inflammation)
2003. 09.01.2003. (Spin-Off)
2004. 02.23.2004. (Seattle G. Deal)
2005. 02.18.2005. (Seattle G. Deal)
2005. 04.04.2005. (Executive)
2005. 05.23.2005. (Onco.)
2005. 11.28.2005. (SAR by NMR)
2006. 11.13.2006. (CEO)
2007. 06.26.2007. Onco.>Genentech
2007. 08.31.2007. AstraZeneca
2007. 10.01.2007. (Psoriasis)
2007. 10.18.2007. (1Mole>2 MAb)
2007. 11.12.2007. (Pediatrics>AIDS)
2007. 11.16.2007. (Psoriasis)
2008. 03.13.2008. (GastroEntero.)
2008. 03.19.2008. (TAP Conclusion)
2008. 07.21.2008. Div VP Cancer
2009. 07.13.2009. GSK Onco.>NSCLC
2009. 11.12.2009. Pain>NGF MAb
2009. 12.10.2009. Cardio.>DysLipide
2010. 02.01.2010. Pierre Fabre/Onco
2010. 02.11.2010. AIDS
2010. 03.02.2010. Enanta Pharma>HCV
2010. 03.10.2010. Cataract
2010. 03.15.2010. Cardio.>Stent
2010. 03.30.2010. AstraZeneca
2010. 04.20.2010. Facet Biotech
2010. 05.11.2010. Zydus Cadila
2010. 05.21.2010. Piramal
2010. 05.24.2010. Neuro.>MS
2010. 07.19.2010. AIDS
2010. 07.28.2010. Cardio.>DysLipide
2010. 09.22.2010. Similac Brand
2010. 09.23.2010. Nephro.>CKD
2010. 10.11.2010. Derma.>Psoriasis
2010. 12.07.2010. Oncology
2011. 03.04.2011. Nephro.
2011. 03.29.2011. Point of Care
2011. 04.29.2011. Low Testosterone
2011. 05.06.2011. FDA Approval
2011. 05.10.2011. Diabetes
2011. 05.18.2011. Hepato.>HCV Diag.
2011. 05.19.2011. Cardio.>DysLipide
2011. 05.23.2011. Onco.>NSCLC
2011. 05.24.2011. Cardio.>CAD>Stent
2011. 05.25.2011. CytoMegaloVirus
2011. 06.09.2011. Neuro.>Parkinsons
2011. 06.14.2011. Endo.>EPI>CF
2011. 06.20.2011. Onco.>Prostate C.
2011. 06.21.2011. BioTest AG
2011. 06.24.2011. Nephro.>CKD &
2011. 08.16.2011. CPP
2011. 08.26.2011. Onco.>NSCLC
2011. 09.08.2011. CLI>BTK CLI
2011. 10.19.2011. Sepn. In 2 Co.
2011. 10.22.2011. Neuro.>MS
2011. 10.24.2011. Onco.>Leukemia
2011. 10.27.2011. Diab.>Nutrition
2011. 11.01.2011. FDA Approval
2011. 11.06.2011. RA
2011. 11.07.2011. SpondyloArthritis
2011. 11.08.2011. AS
2011. 11.09.2011. Hepato.>HBV Diag.
2011. 11.15.2011. Cardio.>DysLipide
2011. 11.21.2011. Chagas Disease
2011. 11.28.2011. GSK
2011. 11.30.2011. Vitamin D
2011. 12.12.2011. Reata Pharma.
2012. 02.29.2012. Galapagos/RA
2012. 03.01.2012. Nutrition
2012. 03.06.2012. Merck USA
2012. 03.07.2012. Iliac Artery Dis.
2012. 03.08.2012. Diabetes>Monitor.
2012. 03.15.2012. Derma.>HS
2012. 03.21.2012. Selects AbbVie
2012. 03.30.2012. PLEX-ID
2012. 04.04.2012. Hepato.>HCV Treat
2012. 04.09.2012. JP>Approval
2012. 04.17.2012. Neuro.>PD
2012. 04.17.2012. Onco.>Prostate C.
2012. 04.19.2012. Hepato.>HCV>IFN-
2012. 04.20.2012. Ophthalmo.>iFS
2012. 05.03.2012. Cardio.>Surgery
2012. 05.03.2012. Nutrition>Syngene
2012. 05.15.2012. Cardio.>CAD>DAPT
2012. 06.05.2012. Endometriosis
2012. 06.06.2012. Active PSpA
2012. 07.03.2012. Ophthalmo.>OVD
2012. 07.06.2012. Pneumo.>TB
2012. 07.30.2012. Rheuma.>nr-axSpA
2012. 08.28.2012. Endo>Testosterone
2012. 10.01.2012. Gastro.>UC
2012. 10.17.2012. Hepato.>HCV>IFN-
2012. 10.30.2012. Nutrition
2012. 11.05.2012. Sells Debt Notes
2012. 11.13.2012. Hepato.>HCV>IFN-
2013. 10.25. Mitral Valve Repa..*
2014. 03.28. Vascular>PAD>Stent *
2014. 04.14. Diab.>Diag. &
2014. 05.12. Infectious Dis.
2014. 05.16. Acq. CL>CFR Pharma.
2014. 07.24. Breastfeed Supplement
2014. 08.18. Brain>Concussions
2014. 09.03. Glucose Monitor EU OK
2014. 10.29. Arrhytmia>AFi *
2015. 07.30. CV.>Mitral Val.>2 Acq*
2016. 02.01. Acq. Alere
2017. 01.04. Acq. St. Jude Med. *
2017. 01.12. Arrhytmia>Mapping En*
2017. 02.01. Pacemaker *
2017. 02.02. Zika Virus Diag.
2017. 03.01. Arrhytmia>AFl>Trea*
2017. 03.18. CAD>Stent Bio. *
2017. 05.08. Arrhytmia ICM *
2017. 05.09. Arrhytmia>AFi>Trea*
2017. 08.09. Mitral Valve Repa. TR*
2017. 08.28. HF LVAD *
2017. 09.14. Occluder PFO *
2017. 09.22. Arrhytmia ICD *
2017. 10.16. Pain>CRPS
2017. 10.23. Arrhytmia ICM *
2017. 10.30. CAD>Stent *
2017. 11.06. Mitral Valve Repa..*
2018. 01.02. Hemato.
2018. 03.29. HF LVAD *
2018. 03.29. HF Monitor *
2018. 05.03. Arrhytmia>Mapping Ad*
2018. 05.22. CAD>Stent>Diag. Tool*
2018. 05.23. CAD>Stent *
2018. 05.24. Ocluder LLA *
2018. 07.12. Mitral Valve Repa..*
2018. 07.26. Mitral Valve Replace *
2018. 07.27. Glucose Monitor USA OK
2018. 09.23. Mitral Valve Repa..*
2018. 09.25. Aortic Valve*
2018. 09.26. CV.>Prognostics EU>OK
2018. 10.17. Emergency Medicine*
2018. 11.19. Arrhytmia>MMVT>Trea*
2019. 01.14. Pediatrics>PDA *
2019. 01.16. Mitral Valve Repa..*
2019. 01.21. Arrhytmia>AFi>Trea*
2019. 02.25. Presentation *
2019. 03.19. infectious disease
2019. 05.06. Cardio.>Arrhytmia
2019. 07.11. Transfusion Medicine
2019. 09.25. CV.>Prognostics US>OK
2020. 01.24. Neuro.>PD
2020. 01.30. Cardio.>TMVI>CE Mark
2020. 02.18. Cardio.>Rhythm>CRT-D &
2020. 03.05. Cardio.>TAVI> ..
2020. 03.18. COVID-19>Diag.>USA>OK
2020. 04.09. Cardio.>TR
2020. 04.15. COVID-19 Ab Test
2020. 05.11. COVID-19 Ab Test
2020. 07.06. Cardio.>FDA Approval
2020. 07.23. Pain & Movement DISs
2020. 11.10. Pain>RF Ablation>USA>L
2020. 12.02. Endo.>Diabetes
2021. 01.11. CONCUSSIONS
2021. 09.02. Acq. Walk Vascular
2022. 12.19. Chronic Pain>USA>OK
2023. 01.17. USA FDA Approval
2023. 01.26. USA FDA Approval
2023. 03.06. USA FDA Approval
2023. 03.07. USA FDA Approval
2023. 04.27. Acq. CSI Completed
2023. 07.05. Cardio.>FDA Approval
2023. 09.22. Acq. Bigfoot Biomedica
2024. 04.29. USA FDA Approval
2024. 06.10. U.S. FDA CLEARANCE
2024. 09.05. CGM USA Launch
Abbott Diabetes/P C2
Abbott Diagnostics C2
Abbott GmbH & Co. KG./P C2
Abbott Medical Optics/P C2
Abbott Point of Care Inc./P C2
Abbott Vascular/P C2
Ibis Biosciences Inc./P C2
Patents
Web-Site
Z - OK

Abbott Laboratories Inc./P C2's products
This section has no products